IGEA Pharma N.V. announced important changes in its board of directors. As announced new persons were bindingly nominated for election as non-executive directors in the board of IGEA at the upcoming extraordinary general meeting of 28 April 2021. Coming from various economic environments, the new board members will bring years of experience and leadership to help the combined businesses of IGEA and Blue Sky Natural Resources LTD to establish market position for health prevention, pharmaceutical, nutraceutical and cosmeceutical solutions based on CBD and other high quality vegetable matrices extracts, leverage commercial capabilities and partnerships, and capitalize on the financial leverage and operational synergies to improve return on capital and achieve profitability. The new persons nominated for election in the general meeting include: Giovanna Puppo, Equity Partner at Grimaldi Studio Legale, Milan; Massimiliano Colella, group CEO at EVERCARE, Dubai; Raffaele Bruto Bertoni, Head of Debt Capital Market and Senior Portfolio Manager at GIC Gulf Investment Corporation, Kuwait City.